肝炎后肝硬化

目的：为探讨肝硬化患者生长激素（GH）的变化，对78例肝炎后肝硬化患者进行临床观察。

Objective : To study the changes of growth hormone ( GH ) levels in posthepatic cirrhosis .

肝炎后肝硬化患者血浆生长激素水平的变化

Changes of growth hormone levels in patients with posthepatic cirrhosis

螺旋CT门静脉血管造影对肝炎后肝硬化门静脉高压的诊断和评价

Application of spiral CT portography in diagnosis of portal hypertension in hepatitis cirrhosis

CT诊断早期肝炎后肝硬化与临床病理对照分析

Comparative Analysis on CT Diagnosis of Early Posthepatitic Cirrhosis and Clinical Pathology Results

前列腺素E1治疗肝炎后肝硬化46例临床观察

Clinical observation of prostaglandin E_1 on treating 46 cases of posthepatitic cirrhosis

肝炎后肝硬化的门静脉系及门体侧支CT表现

CT Manifestations of Portal Venous System and Portal - Systemic Collateral Circulation in Posthepatitis Cirrhosis

肝炎后肝硬化肝脏体积变化与肝功能相关的CT研究

The correlation between hepatic lobe volume as evaluated by computed tomography and liver function reserve in post-hepatitis cirrhotic patients

肝炎后肝硬化脑波谱改变与肝脏MRI表现的相关性研究

Analysis on the correlation between the alterations of the cerebral magnetic resonance spectroscopy and the MRI findings of the liver in post-hepatitic cirrhosis

探讨安化丸治疗肝炎后肝硬化（PHC）的疗效。

This study was to investigate the effect of An Hua pill in treating posthepatitis cirrhosis .

肝炎后肝硬化患者机体氧代谢指标与Child-Pugh分级的关系

Relationship between systemic oxygen metabolism and Child-Pugh score in cirrhotic patients

目的探讨肝炎后肝硬化病人血清甘氨胆酸（CG）值对肝硬化进展和预后的临床意义。

Objective To evaluate the clinical significance of serum CG in the progress and prognosis of patients with posthepatic cirrhosis .

对45例肝炎后肝硬化及40例健康对照者进行血清甲状腺激素（T3、rT3、T4）检测。

Serum thyroid hormone ( T_3 , rT_3 and T_4 ) were determined in 45 cases of posthepatitic cirrhosis and in 40 healthy subjects .

HBV持续感染是导致慢性肝炎后肝硬化、肝细胞癌等疾病的重要原因，尚缺乏能彻底治疗的手段。

Chronic hepatitis B virus ( HBV ) infection , which can lead to the development of liver cirrhosis and hepatocellular carcinoma , is lack of effective treatments currently .

结论血清IL-6和IL-8水平是反映乙型肝炎后肝硬化肝功能损害程度及判断病情预后的重要指标。

Conclusion IL-6 and IL-8 were important target to reflect hepatic function damage of type B posthepatitic cirrhosis and to judge prognosis of posthepatic cirrhosis .

肝炎后肝硬化患者血清总胆汁酸及肝纤维化指标与child-pugh分级关系

Relation of Total Serum Bile Acid and Indexes of Liver Fibrosis to the Child-Pugh Grading

结论病毒性肝炎后肝硬化患者肠道黏膜受损是导致SBP的主要原因之一，测定病毒性肝硬化患者血清中DAO活性及尿中L/M比值可以探知肠黏膜结构及其功能有无损害。

Conclusions The impairment of intestinal function barrier is one of the primary causes of spontaneous bacterial peritonitis in patients with post hepatitis cirrhosis .

高水平IL-8、TNF-α在肝炎后肝硬化合并SBP者发生肾功能损害中可能起一定作用。

Higher levels of IL-8 and TNF - α in cirrhotic patients with SBP may possibly play a role in the pathogenesis of renal function impairment .

方法：搜集256例肝炎后肝硬化并门静脉高压侧支血管形成患者的MSCT资料。

Methods : Two hundred and fifty six cases with liver cirrhosis and portal hypertension were included in this group and underwent upper abdomen examination with MSCT .

结论乙型肝炎后肝硬化病血浆PT、APTT、Fbg，可作为判定病变程度的指标，可对预后作出有价值的判断，为治疗提供依据。

[ Conclusion ] The plasma PT , APTT and Fbg are useful markers for determining the degrees of the disease , it also provide basis for the treatment .

结论：ET-1、CGRP、TNF-α和IL-8水平是反映肝炎后肝硬化肝脏损害程度，可作为预后判断的重要指标。

Conclusion : ET-1 、 CGRP 、 TNF - α and IL-8 were important indexs which reflected the degree of liver damage and estimated the prognosis in posthepatitic cirrhosis .

目的了解TNF-α，IL-6对肝损害的作用，研究口服大黄水治疗对肝炎后肝硬化患者血清TNF-α，IL-6的影响。

Objective To research for liver injury effects of TNF - α and IL-6 , and the effects of oral DaHuang water on serum levels of TNF - α, IL-6 in patients with posthepatitis liver cirrhosis .

方法利用微量聚合酶链反应-序列特异性引物（PCR-SSP）技术，分别检测乙型肝炎后肝硬化患者、乙型肝炎病毒携带者和正常对照人群的HLA-DR/DQ基因型。

Methods Analyze the HLA-DR / DQ genotypes of patients with post-hepatitis B liver cirrhosis , HBV carriers and healthy population by PCR-SSP .

方法：回顾性分析对38例肝炎后肝硬化性门静脉高压症患者实行改良Sugiura手术治疗的情况。

Methods : 38 patients with portal hypertension of liver cirrhosis after hepatitis performed with modified sugiura operation were analysed retrospectively .

结论Child-Pugh分级反映了肝炎后肝硬化患者的肝功能状况，随着肝损害程度的增加，机体氧利用障碍加重。

Conclusion Child-Pugh classification reflects the liver function of the patients which means that the utilization disturbance of oxygen will be worsened by the increased liver lesion .

在家兔腹背贴磁片，每一磁片的磁感应强度0.2T。穴位贴磁药对肝炎后肝硬化患者肝功能的保护

Protective actions of acupoint magnetic medicated plaster therapy on hepatic function in the patient of cirrhosis after hepatitis

方法：应用双单克隆抗体夹心法酶联免疫吸附测定（ELISA）和放射免疫测定（RIA）检测36例肝炎后肝硬化患者血清和腹水中IL-8、TNF-α的含量及动态活性变化。

Methods : Dynamic changes of the serum and ascitic fluid levels of IL-8 and TNF - α in 36 patients with cirrhosis were detected by double-monoclonal-antibody enzyme-linked immunosorbent assay ( ELISA ) and radioimmunoassay ( RIA ) .

方法选择肝炎后肝硬化伴有HPS（23例）和无HPS肝硬化患者（25例），分别进行血气分析和肺功能测定。

METHODS Pulmonary function assay and blood gas analysis were performed in cirrhotic patients with HPS ( HPS , 23 cases ) and without HPS ( HC , 25 cases ) .

方法：采用ELISA法检测了40例原发性肝癌患者，36例肝炎后肝硬化患者和33名健康人的血清中IL10，IL12和TNFα的浓度。

Methods : serum IL 10 , IL 12 , TNF α in 40 patients with PHC , 36 cases with hepatocirrhosis and 33 normal controls were measured with ELISA .

结论：肝炎后肝硬化患者免疫力低下，易出现各种并发症及MOF，死亡率高，临床上宜尽早诊断治疗。

Conclusions : Patients with post-hepatitis cirrhosis have lower immunity and are vulnerable to various complications and MOF . As the death rate is high , early diagnosis and treatment are essential .

肝炎后肝硬化的HBeAg阳性率（16/49）与原发性肝癌组的（10/50）均低于慢性乙型肝炎组（30/51）（P<0.05，P<0.01）；

The HBeAg positive rate in hepatocirrhosis ( 16 / 49 ) and PHC ( 10 / 50 ) was lower than in CHB ( 30 / 51 )( P < 0.05 , P < 0.01 ) .